Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2020

01-01-2020 | Care | Concise Research Report

Managed Health Care and Utilization of Fecal Occult Blood Testing for Colorectal Cancer Screening: a National Database Study

Authors: Daniel Bushyhead, MD, Paul Fishman, PhD

Published in: Journal of General Internal Medicine | Issue 1/2020

Login to get access

Excerpt

The United States Preventive Services Task Force (USPSTF) recommends colorectal cancer screening in adults aged 50 to 75 using either fecal occult blood testing (including fecal immunochemical test) or lower endoscopy.1 However, in 2015, less than two-thirds of eligible adults were compliant with these screening recommendations.2 …
Literature
1.
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315:2564-2575.CrossRef
2.
White A., Thompson T.D., White M.C., et al: Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 66: pp. 201-206.CrossRef
3.
Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 2016;164:456-63.CrossRef
4.
Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res 2004;39:1751–72.CrossRef
5.
Shariff-Marco S, Breen N, Stinchcomb DG, Klabunde CN. Multilevel predictors of colorectal cancer screening use in California. Am J Manag Care 2013;19(3):205–216.PubMedPubMedCentral
6.
Subramanian S, Tangka FKL, Hoover S, et al. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening. Eval Program Plann 2017;62:73-80.CrossRef
Metadata
Title
Managed Health Care and Utilization of Fecal Occult Blood Testing for Colorectal Cancer Screening: a National Database Study
Authors
Daniel Bushyhead, MD
Paul Fishman, PhD
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05504-7

Other articles of this Issue 1/2020

Journal of General Internal Medicine 1/2020 Go to the issue

Letter to the Editor

Vitamin K Antagonist Use and Fracture

Original Research

Primary Care Providers’ Acceptance of Pharmacists’ Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease

Innovation and Improvement: Innovations in Medical Education

ECHO Care: Providing Multidisciplinary Specialty Expertise to Support the Care of Complex Patients

Original Research

Mortality Among Veterans with Major Mental Illnesses Seen in Primary Care: Results of a National Study of Veteran Deaths

Original Research

Frontline Perspectives on Physician Burnout and Strategies to Improve Well-Being: Interviews with Physicians and Health System Leaders

Concise Research Report

The Effect of Exposure to Disaster on Cancer Survival
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits